New Risk • May 28
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Canadian stocks, typically moving 14% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Less than 1 year of cash runway based on free cash flow trend (-US$17m free cash flow). Minor Risks Share price has been volatile over the past 3 months (14% average weekly change). Market cap is less than US$100m (CA$109.6m market cap, or US$79.4m). Reported Earnings • May 15
First quarter 2026 earnings released: EPS: US$0.005 (vs US$0.01 loss in 1Q 2025) First quarter 2026 results: EPS: US$0.005 (up from US$0.01 loss in 1Q 2025). Revenue: US$2.90m (down 92% from 1Q 2025). Net income: US$301.0k (up US$9.18m from 1Q 2025). Profit margin: 10% (up from net loss in 1Q 2025). Over the last 3 years on average, earnings per share has increased by 78% per year but the company’s share price has fallen by 52% per year, which means it is significantly lagging earnings. Announcement • Apr 14
Invesque Inc., Annual General Meeting, Jun 17, 2026 Invesque Inc., Annual General Meeting, Jun 17, 2026. Reported Earnings • Mar 20
Full year 2025 earnings released: US$0.029 loss per share (vs US$0.58 loss in FY 2024) Full year 2025 results: US$0.029 loss per share (improved from US$0.58 loss in FY 2024). Revenue: US$78.1m (down 53% from FY 2024). Net loss: US$30.6m (loss narrowed 14% from FY 2024). Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has fallen by 52% per year, which means it is significantly lagging earnings. Announcement • Mar 20
Invesque Inc. Reports Impairment of Property, Plant and Equipment for the Fourth Quarter Ended December 31, 2025 Invesque Inc. reported Impairment of property, plant and equipment for the fourth quarter ended December 31, 2025. For the quarter, the company reported Impairment of property, plant and equipment of $1,164,000 against $985,000 a year ago. New Risk • Jan 16
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Canadian stocks, typically moving 15% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Less than 1 year of cash runway based on free cash flow trend (-US$14m free cash flow). Minor Risks Share price has been volatile over the past 3 months (15% average weekly change). Market cap is less than US$100m (CA$137.1m market cap, or US$98.5m). New Risk • Nov 09
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -US$14m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$14m free cash flow). Shareholders have been substantially diluted in the past year (over 15x increase in shares outstanding). Minor Risk Market cap is less than US$100m (CA$105.1m market cap, or US$74.9m). Announcement • Nov 08
Invesque Inc. Reports Impairment Charges for the Third Quarter Ended September 30, 2025 Invesque Inc. reported impairment charges for the third quarter ended September 30, 2025. For the quarter, the company reported Impairment of property, plant and equipment was $44,000 against $280,000 a year ago. Reported Earnings • Aug 08
Second quarter 2025 earnings released: EPS: US$0.02 (vs US$0.27 loss in 2Q 2024) Second quarter 2025 results: EPS: US$0.02 (up from US$0.27 loss in 2Q 2024). Revenue: US$29.8m (down 27% from 2Q 2024). Net income: US$16.0m (up US$31.1m from 2Q 2024). Profit margin: 54% (up from net loss in 2Q 2024). Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has fallen by 58% per year, which means it is significantly lagging earnings. Buy Or Sell Opportunity • Aug 07
Now 22% undervalued after recent price drop Over the last 90 days, the stock has fallen 7.7% to CA$0.12. The fair value is estimated to be CA$0.15, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 9.9% over the last 3 years. Earnings per share has declined by 6.5%. New Risk • Aug 06
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Canadian stocks, typically moving 18% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (18% average weekly change). Shareholders have been substantially diluted in the past year (over 15x increase in shares outstanding). Minor Risk Market cap is less than US$100m (CA$137.1m market cap, or US$99.8m). Reported Earnings • May 15
First quarter 2025 earnings released: US$0.01 loss per share (vs US$0.10 loss in 1Q 2024) First quarter 2025 results: US$0.01 loss per share. Revenue: US$37.6m (down 13% from 1Q 2024). Net loss: US$8.88m (loss widened 52% from 1Q 2024). Announcement • Apr 15
Invesque Inc., Annual General Meeting, Jun 18, 2025 Invesque Inc., Annual General Meeting, Jun 18, 2025. Location: indiana, fishers United States Reported Earnings • Mar 20
Full year 2024 earnings released: US$0.58 loss per share (vs US$1.59 loss in FY 2023) Full year 2024 results: US$0.58 loss per share (improved from US$1.59 loss in FY 2023). Revenue: US$170.4m (down 13% from FY 2023). Net loss: US$35.7m (loss narrowed 60% from FY 2023). Over the last 3 years on average, earnings per share has fallen by 44% per year but the company’s share price has fallen by 54% per year, which means it is performing significantly worse than earnings. Announcement • Mar 20
Invesque Inc. Reports Impairment of Property, Plant and Equipment for the Fourth Quarter Ended December 31, 2024 Invesque Inc. reported impairment of property, plant and equipment for the fourth quarter ended December 31, 2024. For the quarter, the company reported impairment of property, plant and equipment of $985,000 against $5,147,000 a year ago. New Risk • Mar 19
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: CA$137.1m (US$95.7m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Shareholders have been substantially diluted in the past year (over 15x increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (16% average weekly change). Market cap is less than US$100m (CA$137.1m market cap, or US$95.7m). New Risk • Jan 08
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Over 15x increase in shares outstanding. This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (21% average weekly change). Shareholders have been substantially diluted in the past year (over 15x increase in shares outstanding). Minor Risk Market cap is less than US$100m (CA$109.6m market cap, or US$76.3m). Reported Earnings • Nov 08
Third quarter 2024 earnings released: US$0.13 loss per share (vs US$0.013 profit in 3Q 2023) Third quarter 2024 results: US$0.13 loss per share (down from US$0.013 profit in 3Q 2023). Revenue: US$42.6m (down 4.4% from 3Q 2023). Net loss: US$7.29m (down US$8.05m from profit in 3Q 2023). Announcement • Nov 08
Invesque Inc. Reports Impairment Charges for the Third Quarter Ended September 30, 2024 Invesque Inc. reported impairment Charges for the third quarter ended September 30, 2024. For the quarter, the company reported impairment of property, plant and equipment of USD 280,000 compared to USD 3,636,000 a year ago. Buy Or Sell Opportunity • Nov 01
Now 22% undervalued after recent price drop Over the last 90 days, the stock has fallen 58% to CA$0.11. The fair value is estimated to be CA$0.14, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 2.7% over the last 3 years. Earnings per share has declined by 30%. Buy Or Sell Opportunity • Sep 20
Now 27% overvalued Over the last 90 days, the stock has fallen 5.4% to CA$0.17. The fair value is estimated to be CA$0.14, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 2.7% over the last 3 years. Earnings per share has declined by 30%. Board Change • Sep 01
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 2 highly experienced directors. Lead Independent Director Gail Steinel was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Aug 14
Second quarter 2024 earnings released: US$0.27 loss per share (vs US$0.81 loss in 2Q 2023) Second quarter 2024 results: US$0.27 loss per share (improved from US$0.81 loss in 2Q 2023). Revenue: US$42.5m (down 19% from 2Q 2023). Net loss: US$15.1m (loss narrowed 67% from 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 30% per year but the company’s share price has fallen by 60% per year, which means it is performing significantly worse than earnings. Announcement • Aug 09
An undisclosed buyer acquired skilled nursing facility in Wisconsin from Invesque Inc. (TSX:IVQ) for $5060. An undisclosed buyer acquired skilled nursing facility in Wisconsin from Invesque Inc. (TSX:IVQ) for $5060 on June 24, 2024.
An undisclosed buyer completed the acquisition of skilled nursing facility in Wisconsin from Invesque Inc. (TSX:IVQ) on June 24, 2024. New Risk • May 28
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: CA$13.5m (US$9.90m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 4.6% per year over the past 5 years. Market cap is less than US$10m (CA$13.5m market cap, or US$9.90m). Minor Risk Share price has been volatile over the past 3 months (18% average weekly change). Reported Earnings • May 10
First quarter 2024 earnings released: US$0.10 loss per share (vs US$0.19 loss in 1Q 2023) First quarter 2024 results: US$0.10 loss per share (improved from US$0.19 loss in 1Q 2023). Revenue: US$45.4m (down 2.9% from 1Q 2023). Net loss: US$5.83m (loss narrowed 47% from 1Q 2023). Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has fallen by 57% per year, which means it is performing significantly worse than earnings. Announcement • Apr 13
Invesque Inc., Annual General Meeting, Jun 20, 2024 Invesque Inc., Annual General Meeting, Jun 20, 2024. Buy Or Sell Opportunity • Apr 02
Now 21% undervalued The stock has been flat over the last 90 days, currently trading at CA$0.33. The fair value is estimated to be CA$0.42, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 23%. Announcement • Mar 16
Invesque Inc. Reports Impairment of Property, Plant and Equipment for the Fourth Quarter Ended December 31, 2023 Invesque Inc. reported impairment of property, plant and equipment for the fourth quarter ended December 31, 2023. For the quarter, the company reported impairment of property, plant and equipment of $5,147,000 against $4,513,000 a year ago. Buy Or Sell Opportunity • Feb 23
Now 22% undervalued Over the last 90 days, the stock has risen 40% to CA$0.42. The fair value is estimated to be CA$0.54, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 42%. New Risk • Nov 22
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Canadian stocks, typically moving 18% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (18% average weekly change). Earnings have declined by 12% per year over the past 5 years. Minor Risk Market cap is less than US$100m (CA$19.1m market cap, or US$14.0m). Reported Earnings • Nov 11
Third quarter 2023 earnings released: EPS: US$0.01 (vs US$0.22 loss in 3Q 2022) Third quarter 2023 results: EPS: US$0.01 (up from US$0.22 loss in 3Q 2022). Revenue: US$47.3m (down 5.1% from 3Q 2022). Net income: US$751.0k (up US$13.2m from 3Q 2022). Profit margin: 1.6% (up from net loss in 3Q 2022). Over the last 3 years on average, earnings per share has increased by 42% per year but the company’s share price has fallen by 48% per year, which means it is significantly lagging earnings. Buying Opportunity • Sep 15
Now 22% undervalued after recent price drop Over the last 90 days, the stock is down 53%. The fair value is estimated to be CA$0.63, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 47%. Reported Earnings • Aug 14
Second quarter 2023 earnings released: US$0.82 loss per share (vs US$0.16 loss in 2Q 2022) Second quarter 2023 results: US$0.82 loss per share (further deteriorated from US$0.16 loss in 2Q 2022). Revenue: US$50.8m (down 6.2% from 2Q 2022). Net loss: US$46.3m (loss widened 401% from 2Q 2022). Over the last 3 years on average, earnings per share has increased by 47% per year but the company’s share price has fallen by 27% per year, which means it is significantly lagging earnings. Announcement • Aug 10
Invesque Inc. to Report Q2, 2023 Results on Aug 14, 2023 Invesque Inc. announced that they will report Q2, 2023 results Pre-Market on Aug 14, 2023 Announcement • Jul 14
Invesque Inc. Announces Chief Financial Officer Changes Invesque Inc. announced that Adlai Chester will assume the Chief Financial Officer role in addition to leading the Company's investment group. Adlai Chester has more than 20 years of finance, real estate, investment, development, and capital markets experience, and has positioned himself as a leader in the health care real estate industry. Prior to his current role at Invesque, he served as Chief Financial Officer of HealthLease Properties. Scott Higgs, the current Chief Financial Officer of the Company, will resign effective August 1, 2023, to pursue other interests. He will remain on as a consultant until year-end. Reported Earnings • May 11
First quarter 2023 earnings released: US$0.19 loss per share (vs US$0.10 profit in 1Q 2022) First quarter 2023 results: US$0.19 loss per share (down from US$0.10 profit in 1Q 2022). Revenue: US$51.8m (up 7.3% from 1Q 2022). Net loss: US$11.0m (down 294% from profit in 1Q 2022). Over the last 3 years on average, earnings per share has increased by 52% per year but the company’s share price has fallen by 30% per year, which means it is significantly lagging earnings. Reported Earnings • Mar 16
Full year 2022 earnings released: US$0.74 loss per share (vs US$0.22 loss in FY 2021) Full year 2022 results: US$0.74 loss per share (further deteriorated from US$0.22 loss in FY 2021). Revenue: US$198.7m (down 7.0% from FY 2021). Net loss: US$42.0m (loss widened 243% from FY 2021). Revenue is forecast to grow 2.8% p.a. on average during the next 2 years, compared to a 5.2% growth forecast for the Real Estate industry in Canada. Over the last 3 years on average, earnings per share has increased by 39% per year but the company’s share price has fallen by 28% per year, which means it is significantly lagging earnings. Reported Earnings • Nov 10
Third quarter 2022 earnings released: US$0.24 loss per share (vs US$0.09 loss in 3Q 2021) Third quarter 2022 results: US$0.24 loss per share (further deteriorated from US$0.09 loss in 3Q 2021). Revenue: US$50.1m (down 5.8% from 3Q 2021). Net loss: US$12.4m (loss widened 145% from 3Q 2021). Over the last 3 years on average, earnings per share has increased by 29% per year but the company’s share price has fallen by 46% per year, which means it is significantly lagging earnings. Announcement • Oct 08
Invesque Inc. to Report Q3, 2022 Results on Nov 08, 2022 Invesque Inc. announced that they will report Q3, 2022 results After-Market on Nov 08, 2022 Announcement • Aug 31
Hillcrest Health Service System, Inc. acquired Two Skilled Nursing Facilities Comprised of 148 Beds in Nebraska from Invesque Inc. (TSX:IVQ) for $24.9 million. Hillcrest Health Service System, Inc. acquired Two Skilled Nursing Facilities Comprised of 148 Beds in Nebraska from Invesque Inc. (TSX:IVQ) for $24.9 million on August 30, 2022. Proceeds from the sale were used by the Company to pay down debt associated with its credit facility with Key Bank, continuing its strategy to de-lever and simplify its balance sheet.
Hillcrest Health Service System, Inc. completed the acquisition of Two Skilled Nursing Facilities Comprised of 148 Beds in Nebraska from Invesque Inc. (TSX:IVQ) on August 30, 2022. Reported Earnings • Aug 11
Second quarter 2022 earnings released: US$0.17 loss per share (vs US$0.062 loss in 2Q 2021) Second quarter 2022 results: US$0.17 loss per share (down from US$0.062 loss in 2Q 2021). Revenue: US$49.8m (down 5.4% from 2Q 2021). Net loss: US$9.24m (loss widened 164% from 2Q 2021). Announcement • Jul 29
Centurion Asset Management Inc. and Appelt Properties Inc. acquired Healthcare Real Estate Portfolio Located in Ontario and Alberta from Invesque Inc. (TSX:IVQ) for CAD 94.6 million. Centurion Asset Management Inc. and Appelt Properties Inc. acquired Healthcare Real Estate Portfolio Located in Ontario and Alberta from Invesque Inc. (TSX:IVQ) for CAD 94.6 million on July 28, 2022. The pricing for the nine properties was equal to CA$265 per rentable square foot and represented a 5.0% cap rate on trailing NOI.
Centurion Asset Management Inc. and Appelt Properties Inc. completed the acquisition of Healthcare Real Estate Portfolio Located in Ontario and Alberta from Invesque Inc. (TSX:IVQ) on July 28, 2022. Announcement • Jul 09
Invesque Inc. to Report Q2, 2022 Results on Aug 09, 2022 Invesque Inc. announced that they will report Q2, 2022 results After-Market on Aug 09, 2022 Reported Earnings • May 13
First quarter 2022 earnings released: EPS: US$0.06 (vs US$0.032 in 1Q 2021) First quarter 2022 results: EPS: US$0.06 (up from US$0.032 in 1Q 2021). Revenue: US$52.2m (down 4.8% from 1Q 2021). Net income: US$3.34m (up 85% from 1Q 2021). Profit margin: 6.4% (up from 3.3% in 1Q 2021). Over the next year, revenue is expected to shrink by 3.9% compared to a 5.3% growth forecast for the industry in Canada. Announcement • May 04
Invesque Inc. to Report Q1, 2022 Results on May 11, 2022 Invesque Inc. announced that they will report Q1, 2022 results After-Market on May 11, 2022 Announcement • Apr 16
Invesque Inc., Annual General Meeting, Jun 22, 2022 Invesque Inc., Annual General Meeting, Jun 22, 2022. Recent Insider Transactions Derivative • Apr 02
Chairman & CEO exercised options to buy CA$88k worth of stock. On the 25th of March, Scott White exercised options to buy 49k shares at a strike price of around CA$1.66, costing a total of CA$82k. This transaction amounted to 13% of their direct individual holding at the time of the trade. Since September 2021, Scott's direct individual holding has increased from 302.17k shares to 415.46k. Company insiders have collectively bought CA$470k more than they sold, via options and on-market transactions, in the last 12 months. Reported Earnings • Mar 13
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Full year 2021 results: US$0.22 loss per share (up from US$3.30 loss in FY 2020). Revenue: US$214.2m (up 3.0% from FY 2020). Net loss: US$12.2m (loss narrowed 93% from FY 2020). Revenue was in line with analyst estimates. Over the next year, revenue is expected to shrink by 6.6% compared to a 7.3% growth forecast for the industry in Canada. Announcement • Feb 02
Invesque Inc. to Report Q4, 2021 Results on Mar 09, 2022 Invesque Inc. announced that they will report Q4, 2021 results After-Market on Mar 09, 2022 Recent Insider Transactions Derivative • Jan 17
Chairman & CEO exercised options to buy CA$143k worth of stock. On the 10th of January, Scott White exercised 110.42k options to receive shares at no cost, then sold around 46.44k of them at CA$2.50 each and kept the remainder. Since March 2021, Scott has owned 302.17k shares directly. Company insiders have collectively bought CA$639k more than they sold, via options and on-market transactions, in the last 12 months. Reported Earnings • Nov 13
Third quarter 2021 earnings released: US$0.09 loss per share (vs US$1.09 loss in 3Q 2020) The company reported a solid third quarter result with reduced losses, improved revenues and improved control over expenses. Third quarter 2021 results: Revenue: US$52.9m (up 1.6% from 3Q 2020). Net loss: US$5.08m (loss narrowed 92% from 3Q 2020). Reported Earnings • Aug 12
Second quarter 2021 earnings released: US$0.06 loss per share (vs US$0.54 loss in 2Q 2020) The company reported a solid second quarter result with reduced losses, improved revenues and improved control over expenses. Second quarter 2021 results: Revenue: US$54.3m (up 6.7% from 2Q 2020). Net loss: US$3.50m (loss narrowed 88% from 2Q 2020). Executive Departure • May 17
Independent Director has left the company On the 12th of May, Donna Brandin's tenure as Independent Director ended after 1.9 years in the role. We don't have any record of a personal shareholding under Donna's name. A total of 2 executives have left over the last 12 months. Executive Departure • May 17
Lead Independent Director has left the company On the 12th of May, Charles Herman's tenure as Lead Independent Director ended after 2.2 years in the role. We don't have any record of a personal shareholding under Charles' name. A total of 2 executives have left over the last 12 months. Reported Earnings • May 14
First quarter 2021 earnings released: EPS US$0.03 (vs US$1.04 loss in 1Q 2020) The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: US$53.8m (up 9.9% from 1Q 2020). Net income: US$1.80m (up US$58.7m from 1Q 2020). Profit margin: 3.3% (up from net loss in 1Q 2020). Recent Insider Transactions Derivative • Mar 29
Chairman & CEO exercised options to buy CA$164k worth of stock. On the 23rd of March, Scott White exercised options to buy 50k shares at a strike price of around CA$3.44, costing a total of CA$171k. This transaction amounted to 20% of their direct individual holding at the time of the trade. Since June 2020, Scott's direct individual holding has increased from 207.81k shares to 252.37k. Company insiders have collectively bought CA$470k more than they sold, via options and on-market transactions, in the last 12 months. Announcement • Mar 16
Invesque Inc., Annual General Meeting, May 18, 2021 Invesque Inc., Annual General Meeting, May 18, 2021. Analyst Estimate Surprise Post Earnings • Mar 14
Revenue beats expectations Revenue exceeded analyst estimates by 1.6%. Over the next year, revenue is forecast to stay flat compared to a 7.2% growth forecast for the Real Estate industry in Canada. Reported Earnings • Mar 14
Full year 2020 earnings released: US$3.30 loss per share (vs US$0.099 loss in FY 2019) The company reported a mediocre full year result with increased losses and weaker control over costs, although revenues improved. Full year 2020 results: Revenue: US$208.0m (up 37% from FY 2019). Net loss: US$184.0m (loss widened US$178.6m from FY 2019). Announcement • Mar 12
Invesque Inc. (TSX:IVQ) acquired 32-unit memory care facility located in Rogers, AR. Invesque Inc. (TSX:IVQ) acquired 32-unit memory care facility located in Rogers, AR on March 10, 2021.
Invesque Inc. (TSX:IVQ) completed the acquisition of 32-unit memory care facility located in Rogers, AR on March 10, 2021. Is New 90 Day High Low • Feb 23
New 90-day high: CA$3.20 The company is up 22% from its price of CA$2.63 on 24 November 2020. The Canadian market is up 9.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Real Estate industry, which is up 10.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CA$6.16 per share. Is New 90 Day High Low • Feb 04
New 90-day high: CA$3.10 The company is up 57% from its price of CA$1.97 on 05 November 2020. The Canadian market is up 13% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Real Estate industry, which is up 3.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CA$6.24 per share. Announcement • Jan 23
Invesque Inc. to Report Q4, 2020 Results on Mar 10, 2021 Invesque Inc. announced that they will report Q4, 2020 results After-Market on Mar 10, 2021 Recent Insider Transactions Derivative • Jan 08
Chairman exercised options to buy CA$109k worth of stock. On the 1st of January, Scott White exercised options to buy 44.57k shares at a strike price of around CA$2.29, costing a total of CA$102k. This transaction amounted to 21% of their direct individual holding at the time of the trade. Since March 2020, Scott has owned 207.81k shares directly. Company insiders have collectively bought CA$759k more than they sold, via options and on-market transactions, in the last 12 months. Reported Earnings • Nov 13
Third quarter 2020 earnings released: US$1.09 loss per share The company reported a mediocre third quarter result with increased losses and weaker control over expenses, although revenues were improved. Third quarter 2020 results: Revenue: US$58.0m (up 48% from 3Q 2019). Net loss: US$60.7m (loss widened US$58.4m from 3Q 2019). Is New 90 Day High Low • Oct 22
New 90-day low: CA$2.25 The company is down 20% from its price of CA$2.80 on 24 July 2020. The Canadian market is up 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Real Estate industry, which is up 11% over the same period. Announcement • Oct 20
Invesque Inc. to Report Q3, 2020 Results on Nov 11, 2020 Invesque Inc. announced that they will report Q3, 2020 results at 5:00 PM, Eastern Standard Time on Nov 11, 2020 Is New 90 Day High Low • Oct 02
New 90-day low: CA$2.50 The company is down 23% from its price of CA$3.24 on 03 July 2020. The Canadian market is up 4.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Real Estate industry, which is up 15% over the same period. 
